Sfoglia per Rivista
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study
2020-01-01 Mancuso, Me; Linari, S; Santagostino, E; Bartolozzi, D; D'Ambrosio, R; Borghi, M; Lampertico, P; Peyvandi, F; Castaman, G; Aghemo, A
How to optimize HCV therapy in genotype 2 patients
2013-01-01 Grassi, E; Aghemo, A
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?
2023-01-01 Vogel, Arndt; Lleo, Ana
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
2022-01-01 Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response
2017-01-01 Bruno, S; Di Marco, V; Iavarone, M; Roffi, L; Boccaccio, V; Crosignani, A; Cabibbo, G; Rossi, S; Calvaruso, V; Aghemo, A; Giacomelli, L; Craxi, A; Colombo, M; Maisonneuve, P
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score
2024-01-01 Gerussi, Alessio; Cappadona, Claudio; Bernasconi, Davide Paolo; Cristoferi, Laura; Valsecchi, Maria Grazia; Carbone, Marco; Invernizzi, Pietro; Asselta, Rosanna
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
2020-01-01 Díaz-González, Á; Sanduzzi-Zamparelli, M; Gomes da Fonseca, Ll; Di Costanzo, Gg; Alves, R; Iavarone, M; Leal, C; Sacco, R; Matilla, Am; Hernández-Guerra, M; Aballay Soteras, G; Wörns, Ma; Pinter, M; Varela, M; Ladekarl, M; Chagas, Al; Mínguez, B; Arenas, Ji; Granito, A; Sánchez-Torrijos, Y; Rojas, Á; Rodríguez de Lope, C; Alvares-da-Silva, Mr; Pascual, S; Rimassa, L; Lledó, Jl; Huertas, C; Sangro, B; Giannini, Eg; Delgado, M; Vergara, M; Perelló, C; Lue, A; Sala, M; Gallego, A; Coll, S; Hernáez, T; Piñero, F; Pereira, G; França, A; Marín, J; Anders, M; Mello, V; Lozano, M; Nault, Jc; Menéndez, J; García Juárez, I; Bruix, J; Reig, M
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?
2022-01-01 Terziroli Beretta-Piccoli, Benedetta; Lleo, Ana
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis
2015-01-01 Giannone, Ferdinando; Domenicali, Marco; Baldassarre, Maurizio; Bartoletti, Michele; Naldi, Marina; Laggetta, Maristella; Bertucci, Carlo; Clecchia, A; Viale, Pierluigi; Bernardi, Mauro; Caraceni, Paolo
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis
2021-01-01 Casadei-Gardini, Andrea; Scartozzi, Mario; Tada, Toshifumi; Yoo, Changhoon; Shimose, Shigeo; Masi, Gianluca; Lonardi, Sara; Frassineti, Luca Giovanni; Nicola, Silvestris; Piscaglia, Fabio; Kumada, Takashi; Kim, Hyung-Don; Koga, Hironori; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Bang, Yeonghak; Atsukawa, Masanori; Torimura, Takuji; Tsuj, Kunihiko; Itobayashi, Ei; Toyoda, Hidenori; Fukunishi, Shinya; Rimassa, Lorenza; Rimini, Margherita; Cascinu, Stefano; Cucchetti, Alessandro; Arai, Taeang
Liver International: Anticipating the future of hepatology worldwide
2019-01-01 Valenti, L; Aghemo, A; Forner, A
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey
2021-01-01 Ponziani, Francesca Romana; Aghemo, Alessio; Cabibbo, Giuseppe; Masarone, Mario; Montagnese, Sara; Petta, Salvatore; Russo, Francesco Paolo; Lai, Quirino
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma
2012-01-01 Augello, C.; Vaira, V.; Caruso, L.; Destro, A.; Maggioni, M.; Park, Y. N.; Montorsi, M.; Santambrogio, R.; Roncalli, M.; Bosari, S.
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma
2015-01-01 Vaira, V; Roncalli, M; Carnaghi, C; Faversani, A; Maggioni, M; Augello, C; Rimassa, L; Pressiani, T; Spagnuolo, G; Di Tommaso, L; Fagiuoli, S; Caremoli, Er; Barberis, M; Labianca, R; Santoro, A; Bosari, S
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies
2017-01-01 Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Rossi, P; Barbaliscia, S; Melis, M; Verucchi, G; Magni, Cf; Teti, E; Bertoli, A; Antonucci, F; Bellocchi, Mc; Micheli, V; Masetti, C; Landonio, S; Francioso, S; Santopaolo, F; Pellicelli, Am; Calvaruso, V; Gianserra, L; Siciliano, M; Romagnoli, D; Cozzolongo, R; Grieco, A; Vecchiet, J; Morisco, F; Merli, M; Brancaccio, G; Di Biagio, A; Loggi, E; Mastroianni, Cm; Pace Palitti, V; Tarquini, P; Puoti, M; Taliani, G; Sarmati, L; Picciotto, A; Vullo, V; Caporaso, N; Paoloni, M; Pasquazzi, C; Rizzardini, G; Parruti, G; Craxì, A; Babudieri, S; Andreoni, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F; Mariani, R; Iapadre, N; Grimaldi, A; Cozzolongo, R; Andreone, P; Verucchi, G; Menzaghi, B; Quirino, T; Pisani, V; Torti, C; Vecchiet, J; Bruzzone, B; De Maria, A; Marenco, S; Nicolini, La; Viscoli, C; Casinelli, K; Delle Monache, M; Lichtner, M; Aghemo, A; Boccaccio, V; Bruno, S; Cerrone, M; Colombo, M; D'Arminio Monforte, A; Danieli, E; Donato, F; Gubertini, G; Lleo, A; Magni, Cf; Mancon, A; Monico, S; Niero, F; Russo, Ml; Gnocchi, M; Orro, A; Milanesi, L; Baldelli, E; Bertolotti, M; Borghi, V; Mussini, C; Brancaccio, G; Gaeta, Gb; Lembo, V; Sangiovanni, V; Di Marco, V; Mazzola, A; Petta, S; D'Amico, E; Cacciatore, P; Consorte, A; Pieri, A; Polilli, E; Sozio, F; Antenucci, F; Aragri, M; Baiocchi, L; Barbaliscia, S; Biliotti, E; Biolato, M; Carioti, L; Ceccherini-Silberstein, F; Cerasari, G; Cerva, C; Ciotti, M; D'Ambrosio, C; D'Ettorre, G; De Leonardis, F; De Sanctis, A; Di Maio, Vc; Di Paolo, D; Furlan, C; Gallo, P; Gasbarrini, A; Giannelli, V; Grieco, S; Lambiase, L; Lattanzi, B; Lenci, I; Lula, R; Malagnino, V; Manuelli, M; Miglioresi, L; Milana, M; Moretti, A; Nosotti, L; Palazzo, D; Pellicelli, A; Romano, M; Sarrecchia, C; Sforza, D; Sorbo, Mc; Spaziante, M; Svicher, V; Tisone, G; Vespasiani-Gentilucci, U; D'Adamo, G; Mangia, A; Maida, I; Mura, Ms; Falconi, L; Di Giammartino, D.
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma
2020-01-01 Rimassa, L; Wörns, Ma
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals
2018-01-01 Craviotto, V; Lamonaca, L; Aghemo, A; Lleo, A
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY 2157299) in advanced hepatocellular carcinoma
2019-01-01 Faivre, S; Santoro, A; Kelley, R K; Gane, E; Costentin, C E; Gueorquieva, I; Smith, C; Cleverly, A; Lahn, M M; Raymond, E; Benhadji, K A; Giannelli, G
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
2022-01-01 Marcellusi, Andrea; Mennini, Francesco Saverio; Ruf, Murad; Galli, Claudio; Aghemo, Alessio; Brunetto, Maurizia R; Babudieri, Sergio; Craxi, Antonio; Andreoni, Massimo; Kondili, Loreta A
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
2023-01-01 Murillo Perez, C Fiorella; Ioannou, Stephanie; Hassanally, Iman; Trivedi, Palak J; Corpechot, Christophe; van der Meer, Adriaan J; Lammers, Willem J; Battezzati, Pier Maria; Lindor, Keith D; Nevens, Frederik; Kowdley, Kris V; Bruns, Tony; Cazzagon, Nora; Floreani, Annarosa; Mason, Andrew L; Gulamhusein, Aliya; Ponsioen, Cyriel Y; Carbone, Marco; Lleo, Ana; Mayo, Marlyn J; Dalekos, George N; Gatselis, Nikolaos K; Thorburn, Douglas; Verhelst, Xavier; Parés, Albert; Londoño, Maria-Carlota; Janssen, Harry L A; Invernizzi, Pietro; Vuppalanchi, Raj; Hirschfield, Gideon M; Hansen, Bettina E; Levy, Cynthia
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study | 1-gen-2020 | Mancuso, Me; Linari, S; Santagostino, E; Bartolozzi, D; D'Ambrosio, R; Borghi, M; Lampertico, P; Peyvandi, F; Castaman, G; Aghemo, A | |
How to optimize HCV therapy in genotype 2 patients | 1-gen-2013 | Grassi, E; Aghemo, A | |
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry? | 1-gen-2023 | Vogel, Arndt; Lleo, Ana | |
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma | 1-gen-2022 | Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini | |
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response | 1-gen-2017 | Bruno, S; Di Marco, V; Iavarone, M; Roffi, L; Boccaccio, V; Crosignani, A; Cabibbo, G; Rossi, S; Calvaruso, V; Aghemo, A; Giacomelli, L; Craxi, A; Colombo, M; Maisonneuve, P | |
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score | 1-gen-2024 | Gerussi, Alessio; Cappadona, Claudio; Bernasconi, Davide Paolo; Cristoferi, Laura; Valsecchi, Maria Grazia; Carbone, Marco; Invernizzi, Pietro; Asselta, Rosanna | |
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis | 1-gen-2020 | Díaz-González, Á; Sanduzzi-Zamparelli, M; Gomes da Fonseca, Ll; Di Costanzo, Gg; Alves, R; Iavarone, M; Leal, C; Sacco, R; Matilla, Am; Hernández-Guerra, M; Aballay Soteras, G; Wörns, Ma; Pinter, M; Varela, M; Ladekarl, M; Chagas, Al; Mínguez, B; Arenas, Ji; Granito, A; Sánchez-Torrijos, Y; Rojas, Á; Rodríguez de Lope, C; Alvares-da-Silva, Mr; Pascual, S; Rimassa, L; Lledó, Jl; Huertas, C; Sangro, B; Giannini, Eg; Delgado, M; Vergara, M; Perelló, C; Lue, A; Sala, M; Gallego, A; Coll, S; Hernáez, T; Piñero, F; Pereira, G; França, A; Marín, J; Anders, M; Mello, V; Lozano, M; Nault, Jc; Menéndez, J; García Juárez, I; Bruix, J; Reig, M | |
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19? | 1-gen-2022 | Terziroli Beretta-Piccoli, Benedetta; Lleo, Ana | |
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis | 1-gen-2015 | Giannone, Ferdinando; Domenicali, Marco; Baldassarre, Maurizio; Bartoletti, Michele; Naldi, Marina; Laggetta, Maristella; Bertucci, Carlo; Clecchia, A; Viale, Pierluigi; Bernardi, Mauro; Caraceni, Paolo | |
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis | 1-gen-2021 | Casadei-Gardini, Andrea; Scartozzi, Mario; Tada, Toshifumi; Yoo, Changhoon; Shimose, Shigeo; Masi, Gianluca; Lonardi, Sara; Frassineti, Luca Giovanni; Nicola, Silvestris; Piscaglia, Fabio; Kumada, Takashi; Kim, Hyung-Don; Koga, Hironori; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Bang, Yeonghak; Atsukawa, Masanori; Torimura, Takuji; Tsuj, Kunihiko; Itobayashi, Ei; Toyoda, Hidenori; Fukunishi, Shinya; Rimassa, Lorenza; Rimini, Margherita; Cascinu, Stefano; Cucchetti, Alessandro; Arai, Taeang | |
Liver International: Anticipating the future of hepatology worldwide | 1-gen-2019 | Valenti, L; Aghemo, A; Forner, A | |
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey | 1-gen-2021 | Ponziani, Francesca Romana; Aghemo, Alessio; Cabibbo, Giuseppe; Masarone, Mario; Montagnese, Sara; Petta, Salvatore; Russo, Francesco Paolo; Lai, Quirino | |
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma | 1-gen-2012 | Augello, C.; Vaira, V.; Caruso, L.; Destro, A.; Maggioni, M.; Park, Y. N.; Montorsi, M.; Santambrogio, R.; Roncalli, M.; Bosari, S. | |
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma | 1-gen-2015 | Vaira, V; Roncalli, M; Carnaghi, C; Faversani, A; Maggioni, M; Augello, C; Rimassa, L; Pressiani, T; Spagnuolo, G; Di Tommaso, L; Fagiuoli, S; Caremoli, Er; Barberis, M; Labianca, R; Santoro, A; Bosari, S | |
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies | 1-gen-2017 | Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Rossi, P; Barbaliscia, S; Melis, M; Verucchi, G; Magni, Cf; Teti, E; Bertoli, A; Antonucci, F; Bellocchi, Mc; Micheli, V; Masetti, C; Landonio, S; Francioso, S; Santopaolo, F; Pellicelli, Am; Calvaruso, V; Gianserra, L; Siciliano, M; Romagnoli, D; Cozzolongo, R; Grieco, A; Vecchiet, J; Morisco, F; Merli, M; Brancaccio, G; Di Biagio, A; Loggi, E; Mastroianni, Cm; Pace Palitti, V; Tarquini, P; Puoti, M; Taliani, G; Sarmati, L; Picciotto, A; Vullo, V; Caporaso, N; Paoloni, M; Pasquazzi, C; Rizzardini, G; Parruti, G; Craxì, A; Babudieri, S; Andreoni, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F; Mariani, R; Iapadre, N; Grimaldi, A; Cozzolongo, R; Andreone, P; Verucchi, G; Menzaghi, B; Quirino, T; Pisani, V; Torti, C; Vecchiet, J; Bruzzone, B; De Maria, A; Marenco, S; Nicolini, La; Viscoli, C; Casinelli, K; Delle Monache, M; Lichtner, M; Aghemo, A; Boccaccio, V; Bruno, S; Cerrone, M; Colombo, M; D'Arminio Monforte, A; Danieli, E; Donato, F; Gubertini, G; Lleo, A; Magni, Cf; Mancon, A; Monico, S; Niero, F; Russo, Ml; Gnocchi, M; Orro, A; Milanesi, L; Baldelli, E; Bertolotti, M; Borghi, V; Mussini, C; Brancaccio, G; Gaeta, Gb; Lembo, V; Sangiovanni, V; Di Marco, V; Mazzola, A; Petta, S; D'Amico, E; Cacciatore, P; Consorte, A; Pieri, A; Polilli, E; Sozio, F; Antenucci, F; Aragri, M; Baiocchi, L; Barbaliscia, S; Biliotti, E; Biolato, M; Carioti, L; Ceccherini-Silberstein, F; Cerasari, G; Cerva, C; Ciotti, M; D'Ambrosio, C; D'Ettorre, G; De Leonardis, F; De Sanctis, A; Di Maio, Vc; Di Paolo, D; Furlan, C; Gallo, P; Gasbarrini, A; Giannelli, V; Grieco, S; Lambiase, L; Lattanzi, B; Lenci, I; Lula, R; Malagnino, V; Manuelli, M; Miglioresi, L; Milana, M; Moretti, A; Nosotti, L; Palazzo, D; Pellicelli, A; Romano, M; Sarrecchia, C; Sforza, D; Sorbo, Mc; Spaziante, M; Svicher, V; Tisone, G; Vespasiani-Gentilucci, U; D'Adamo, G; Mangia, A; Maida, I; Mura, Ms; Falconi, L; Di Giammartino, D. | |
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma | 1-gen-2020 | Rimassa, L; Wörns, Ma | |
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals | 1-gen-2018 | Craviotto, V; Lamonaca, L; Aghemo, A; Lleo, A | |
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY 2157299) in advanced hepatocellular carcinoma | 1-gen-2019 | Faivre, S; Santoro, A; Kelley, R K; Gane, E; Costentin, C E; Gueorquieva, I; Smith, C; Cleverly, A; Lahn, M M; Raymond, E; Benhadji, K A; Giannelli, G | |
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation | 1-gen-2022 | Marcellusi, Andrea; Mennini, Francesco Saverio; Ruf, Murad; Galli, Claudio; Aghemo, Alessio; Brunetto, Maurizia R; Babudieri, Sergio; Craxi, Antonio; Andreoni, Massimo; Kondili, Loreta A | |
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival | 1-gen-2023 | Murillo Perez, C Fiorella; Ioannou, Stephanie; Hassanally, Iman; Trivedi, Palak J; Corpechot, Christophe; van der Meer, Adriaan J; Lammers, Willem J; Battezzati, Pier Maria; Lindor, Keith D; Nevens, Frederik; Kowdley, Kris V; Bruns, Tony; Cazzagon, Nora; Floreani, Annarosa; Mason, Andrew L; Gulamhusein, Aliya; Ponsioen, Cyriel Y; Carbone, Marco; Lleo, Ana; Mayo, Marlyn J; Dalekos, George N; Gatselis, Nikolaos K; Thorburn, Douglas; Verhelst, Xavier; Parés, Albert; Londoño, Maria-Carlota; Janssen, Harry L A; Invernizzi, Pietro; Vuppalanchi, Raj; Hirschfield, Gideon M; Hansen, Bettina E; Levy, Cynthia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile